---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-061326"
form_type: "8-K"
ticker: "RVP"
cik: "0000946563"
company_name: "RETRACTABLE TECHNOLOGIES INC"
filed_at: "2023-05-16T23:59:59+00:00"
generated_at: "2026-06-15T00:25:30.513968+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Retractable Q1 2023 sales down 75% to $11.0M; operating loss of $2.7M vs $9.7M profit a year ago

## Summary
- Total net sales $11.0M for Q1 2023, vs $44.7M in Q1 2022; no U.S. government syringe orders.
- Operating loss of $2.7M compared to operating income of $9.7M in prior-year period.
- Domestic unit sales fell 77.4%; international revenue down 70.3% due to fewer vaccination campaign orders.
- Sales & marketing expenses increased ~33% mainly in travel, trade shows, and sales headcount.
- Invested ~$9.0M in U.S. government-backed mutual funds; restructured equity securities by ~$6.0M.

## SEC filing metadata
- accession: 0001104659-23-061326
- form_type: 8-K
- ticker: RVP
- cik: 0000946563
- company_name: RETRACTABLE TECHNOLOGIES INC
- filed_at: 2023-05-16T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946563/000110465923061326/0001104659-23-061326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946563/000110465923061326/tm2315891d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-061326
- JSON: https://secwatch.observer/filing/0001104659-23-061326.json
- Plain text: https://secwatch.observer/filing/0001104659-23-061326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.